242 related articles for article (PubMed ID: 10749573)
1. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.
Ogata N; Chikazu D; Kubota N; Terauchi Y; Tobe K; Azuma Y; Ohta T; Kadowaki T; Nakamura K; Kawaguchi H
J Clin Invest; 2000 Apr; 105(7):935-43. PubMed ID: 10749573
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts.
Akune T; Ogata N; Hoshi K; Kubota N; Terauchi Y; Tobe K; Takagi H; Azuma Y; Kadowaki T; Nakamura K; Kawaguchi H
J Cell Biol; 2002 Oct; 159(1):147-56. PubMed ID: 12379806
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of insulin receptor substrate-1 impairs skeletal growth through early closure of epiphyseal cartilage.
Hoshi K; Ogata N; Shimoaka T; Terauchi Y; Kadowaki T; Kenmotsu S; Chung UI; Ozawa H; Nakamura K; Kawaguchi H
J Bone Miner Res; 2004 Feb; 19(2):214-23. PubMed ID: 14969391
[TBL] [Abstract][Full Text] [Related]
4. [Involvement of insulin and IGF-1 signaling molecules in bone metabolism].
Ogata N; Kawaguchi H
Clin Calcium; 2008 May; 18(5):614-22. PubMed ID: 18445879
[TBL] [Abstract][Full Text] [Related]
5. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
6. [The role of insulin receptor substrates in bone metabolism].
Akune T
Clin Calcium; 2004 Feb; 14(2):289-92. PubMed ID: 15576986
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H
Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
[TBL] [Abstract][Full Text] [Related]
8. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
9. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
10. [Hormones and osteoporosis update. Insulin/IGF-I and bone].
Kawaguchi H
Clin Calcium; 2009 Jul; 19(7):1015-25. PubMed ID: 19568000
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects.
Kenner L; Hoebertz A; Beil FT; Keon N; Karreth F; Eferl R; Scheuch H; Szremska A; Amling M; Schorpp-Kistner M; Angel P; Wagner EF
J Cell Biol; 2004 Feb; 164(4):613-23. PubMed ID: 14769860
[TBL] [Abstract][Full Text] [Related]
12. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
[TBL] [Abstract][Full Text] [Related]
13. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
[TBL] [Abstract][Full Text] [Related]
14. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
15. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
17. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
[TBL] [Abstract][Full Text] [Related]
18. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).
Gao YH; Shinki T; Yuasa T; Kataoka-Enomoto H; Komori T; Suda T; Yamaguchi A
Biochem Biophys Res Commun; 1998 Nov; 252(3):697-702. PubMed ID: 9837769
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
